相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PDL1 Regulation by p53 via miR-34
Maria Angelica Cortez et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
PDL1 Regulation by p53 via miR-34
Maria Angelica Cortez et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Epigenetic Modulators and the New Immunotherapies
Anthony E. Dear
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses
Katherine B. Chiappinelli et al.
CELL (2015)
Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia
Xi Wang et al.
CELLULAR SIGNALLING (2015)
Immune Checkpoint Blockade in Cancer Therapy
Michael A. Postow et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs
Eric Londin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
In Vivo Delivery of miR-34a Sensitizes Lung Tumors to Radiation Through RAD51 Regulation
Maria Angelica Cortez et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2015)
Increased MicroRNA-34b and-34c Predominantly Expressed in Stromal Tissues Is Associated with Poor Prognosis in Human Colon Cancer
Yukiharu Hiyoshi et al.
PLOS ONE (2015)
Quantification of Therapeutic miRNA Mimics in Whole Blood from Nonhuman Primates
Kevin Kelnar et al.
ANALYTICAL CHEMISTRY (2014)
A phase 1 study of the BCL2-targeted deoxyribonucleic acid inhibitor (DNAi) PNT2258 in patients with advanced solid tumors
Anthony W. Tolcher et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
dsRNA-Activation of TLR3 and RLR Signaling: Gene Induction-Dependent and Independent Effects
Saurabh Chattopadhyay et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2014)
Systemic Delivery of a miR34a Mimic as a Potential Therapeutic for Liver Cancer
Christopher L. Daige et al.
MOLECULAR CANCER THERAPEUTICS (2014)
MicroRNA-34a Enhances T Cell Activation by Targeting Diacylglycerol Kinase ζ
Jinwook Shin et al.
PLOS ONE (2013)
MicroRNA Molecular Profiles Associated with Diagnosis, Clinicopathologic Criteria, and Overall Survival in Patients with Resectable Pancreatic Ductal Adenocarcinoma
Nigel B. Jamieson et al.
CLINICAL CANCER RESEARCH (2012)
Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and In Vivo Evidence
Maria T. Di Martino et al.
CLINICAL CANCER RESEARCH (2012)
miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy
Fumihiko Nakatani et al.
JOURNAL OF PATHOLOGY (2012)
Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivo
V. J. Craig et al.
LEUKEMIA (2012)
miR-34 – a microRNA replacement therapy is headed to the clinic
Andreas G. Bader
Frontiers in Genetics (2012)
Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: Prediction and prevention
Janos Szebeni et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
Developing therapeutic microRNAs for cancer
A. G. Bader et al.
GENE THERAPY (2011)
Systemic Delivery of Tumor Suppressor microRNA Mimics Using a Neutral Lipid Emulsion Inhibits Lung Tumors in Mice
Phong Trang et al.
MOLECULAR THERAPY (2011)
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
Can Liu et al.
NATURE MEDICINE (2011)
MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy
Andrea L. Kasinski et al.
NATURE REVIEWS CANCER (2011)
The Promise of MicroRNA Replacement Therapy
Andreas G. Bader et al.
CANCER RESEARCH (2010)
Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor MicroRNA-34
Jason F. Wiggins et al.
CANCER RESEARCH (2010)
The miR-34 family in cancer and apoptosis
H. Hermeking
CELL DEATH AND DIFFERENTIATION (2010)
miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions
Zandra Hagman et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells
Na Li et al.
CANCER LETTERS (2009)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells
Qing Ji et al.
PLOS ONE (2009)
MicroRNA Profiling of BRCA1/2 Mutation-Carrying and Non-Mutation-Carrying High-Grade Serous Carcinomas of Ovary
Cheng-Han Lee et al.
PLOS ONE (2009)
Misinterpreting the Therapeutic Effects of Small Interfering RNA Caused by Immune Stimulation
Marjorie Robbins et al.
HUMAN GENE THERAPY (2008)
A microRNA component of the p53 tumour suppressor network
Lin He et al.
NATURE (2007)
MicroRNA signatures in human cancers
George A. Calin et al.
NATURE REVIEWS CANCER (2006)
Oncomirs - microRNAs with a role in cancer
A Esquela-Kerscher et al.
NATURE REVIEWS CANCER (2006)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
分享论文
